MENGENAI EPISOD INI
Featuring a slide presentation and related discussion from Dr L Elizabeth Budde, including the following topics:
- Overview of approved and investigational CD20 x CD3 bispecific antibodies (BsAbs) in non-Hodgkin lymphoma; key findings from Phase II studies evaluating glofitamab and epcoritamab in relapsed/refractory (R/R) diffuse large B-cell lymphoma (0:00)
- Bringing BsAbs into earlier-line settings; key findings from Phase III studies (7:49)
- Key findings from the Phase III EPCORE DLBCL-1 and EPCORE DLBCL-4 studies and Phase II EPCORE NHL-1 study (14:12)
- A Phase Ib/II study of glofitamab/polatuzumab in R/R large B-cell lymphoma; investigating the use of BsAbs as front-line therapy and as combination therapy (17:58)
- Managing treatment-related adverse events; final takeaways (22:53)
Bahasa Inggeris
Amerika Syarikat
TRANSKRIP 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CARI EPISOD LEPAS
Cari episod lepas bagi Research To Practice | Oncology Videos.
EPISOD LAIN DALAM PODCAST INI
Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:
Introduction (0:00)
EGFR Mutations (2:23)
HER2 Alterations (22:40)
Available and Investigational Immunotherapies (32:14)
Small Cell Lung Cancer (40:48)
CME ...
Featuring an interview with Dr Neeraj Agarwal, including the following topics:
Impact of PTEN deficiency on PI3K/AKT/mTOR pathway; optimal approaches to testing (0:00)
Approaches to monitoring for disease progression in patients who are PTEN deficient; prognostic significance and implication ...
Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics:
Case: A woman in her mid 60s with Stage II uterine carcinosarcoma treated with surgery followed by paclitaxel/carboplatin, whole-pelvic radiation ...
Featuring an interview with Dr L Elizabeth Budde, including the following topics:
Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00)
Management of BsAb-induced cytokine release syndrome and other toxicities (7:35)
Use of BsAbs i ...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada Dr Neil Love, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.
SUNTING
Terima kasih kerana membantu memastikan pangkalan data podcast dalam keadaan terkini.
